Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O):A real-world study on behalf of Meet-URO group (MeetUro-7b).

Marco Stellato,Daniele Santini,Ugo De Giorgi,Elena Verzoni,Chiara Casadei,Giuseppe Fornarini,Marco Maruzzo,Andrea Napolitano,Andrea Sbrana,Giuseppe Di Lorenzo,Mariella Sorarů,Emanuele Naglieri,Sebastiano Buti,Rocco De Vivo,Francesca Vignani,Claudia Mucciarini,Francesco Grillone,Giandomenico Roviello,Sandro Pignata,Giuseppe Procopio

Impact of previous nephrectomy on clinical outcome of metastatic renal carcinoma treated with immune-oncology (I-O):A real-world study on behalf of Meet-URO group (MeetUro-7b).

2020

e17088Background: Immuno-oncology (IO) treatment demonstrated to improve Overall Survival (OS) in metastatic renal cell carcinoma (mRCC). The prognostic impact of previous citoreductive nephrectomy...

Keywords:

Oncology
Immune system
Nephrectomy
Metastatic renal carcinoma
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations